Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | 281 843 | déclaré | 05 janv. 2026 | tx 69+3 466 971−487 166 |
| SYNERGY PHARMACEUTICALS, INC. | 189 056 | déclaré | 28 juin 2017 | tx 4+206 556 |
| BROADRIDGE FINANCIAL SOLUTIONS, INC. | 103 489,99 | déclaré | 01 avr. 2025 | tx 374+8 931 804,03−8 199 746,03 |
| PALISADE BIO, INC. | 100 000 | déclaré | 07 nov. 2017 | tx 8+247 871 |
| AUTOMATIC DATA PROCESSING INC | 0 | déclaré | 02 avr. 2007 | tx 53+419 189,19−808 642,58 |
| Madrona Ventures, Inc. | 0 | déclaré | 02 mars 2023 | tx 14+20 300−20 300 |
| ADT Corp | 0 | déclaré | 02 mai 2016 | tx 18+10 987−10 987 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 05 janv. 2026 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 42 105 | — | |
| 05 janv. 2026 | TAX_WITHHOLDING | CATALYST PHARMACEUTICALS, INC. | 10 577 | — | |
| 05 janv. 2026 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 42 105 | 0.00 USD | deriv |
| 29 déc. 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1 334 | — | |
| 29 déc. 2025 | TAX_WITHHOLDING | CATALYST PHARMACEUTICALS, INC. | 524 | — | |
| 29 déc. 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1 334 | 0.00 USD | deriv |
| 21 nov. 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 20 006 | — | |
| 21 nov. 2025 | TAX_WITHHOLDING | CATALYST PHARMACEUTICALS, INC. | 7 872 | — | |
| 20 nov. 2025 | GRANT_AWARD | CATALYST PHARMACEUTICALS, INC. | 381 948 | 0.00 USD | deriv |
| 20 nov. 2025 | GRANT_AWARD | CATALYST PHARMACEUTICALS, INC. | 115 283 | 0.00 USD | deriv |
| 21 nov. 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 20 006 | 0.00 USD | deriv |
| 26 août 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 50 000 | 2.24 USD | |
| 26 août 2025 | SALE | CATALYST PHARMACEUTICALS, INC. | 22 970 | 20.62 USD | |
| 26 août 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 50 000 | 0.00 USD | deriv |
| 30 mai 2025 | SALE | CATALYST PHARMACEUTICALS, INC. | 70 000 | 24.86 USD | |
| 01 avr. 2025 | TAX_WITHHOLDING | BROADRIDGE FINANCIAL SOLUTIONS, INC. | 604 | 244.72 USD | |
| 14 févr. 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 4 000 | — | |
| 14 févr. 2025 | TAX_WITHHOLDING | CATALYST PHARMACEUTICALS, INC. | 1 574 | — | |
| 14 févr. 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 4 000 | 0.00 USD | deriv |
| 04 févr. 2025 | GRANT_AWARD | BROADRIDGE FINANCIAL SOLUTIONS, INC. | 4 241 | 0.00 USD | deriv |
| 02 janv. 2025 | TAX_WITHHOLDING | CATALYST PHARMACEUTICALS, INC. | 10 600 | — | |
| 02 janv. 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 42 105 | — | |
| 02 janv. 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 42 105 | 0.00 USD | deriv |
| 27 déc. 2024 | TAX_WITHHOLDING | CATALYST PHARMACEUTICALS, INC. | 324 | — | |
| 27 déc. 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1 333 | — |
2 achats déclarés après au moins 12 mois de silence — dernière occurrence le 12 sept. 2019.